SUMMARY The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …

IDSA Disclaimer As of the time of this publication, updates have been made to IDSA's
Guidelines on the Diagnosis of COVID-19. For the most updated version of these guidelines …

Accurate serological assays to detect antibodies to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of SARS-CoV-2 …

Around 2· 5 million deaths and more than 110 million COVID-19 cases have been reported
globally. Although it initially appeared that HIV infection was not a risk factor for COVID-19 or …

Antibody tests for detecting past infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have many uses for public health decision making, but …

Background Neutralization tests (NT) are the gold standard for detecting and quantifying anti-
SARS-CoV-2 neutralizing antibodies (NAb), but their complexity restricts them to research …

Background Antibody testing has recently emerged as an option to assist with determining
exposure to SARS-CoV-2, the causative agent of COVID-19. Elucidation of the kinetics and …

In this article, the editors of Clinical Infectious Diseases review some of the most important
lessons they have learned about the epidemiology, clinical features, diagnosis, treatment …

Timing of detection of immunoglobulin G (IgG), immunoglobulin A (IgA), and
immunoglobulin M (IgM) antibodies against severe acute respiratory syndrome coronavirus …